Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 30 of 30

Type	Event	Organ system	Group	Affected	At risk
serious	Fibromyalgia	Musculoskeletal and connective tissue disorders	Pregabalin	0	170
serious	Fibromyalgia	Musculoskeletal and connective tissue disorders	Placebo	1	164
serious	Cerebral haemangioma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Pregabalin	0	170
serious	Cerebral haemangioma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Placebo	1	164
serious	Cerebral haemorrhage	Nervous system disorders	Pregabalin	0	170
serious	Cerebral haemorrhage	Nervous system disorders	Placebo	1	164
serious	Vaginal haemorrhage	Reproductive system and breast disorders	Pregabalin	0	170
serious	Vaginal haemorrhage	Reproductive system and breast disorders	Placebo	1	164
serious	Nasal obstruction	Respiratory, thoracic and mediastinal disorders	Pregabalin	0	170
serious	Nasal obstruction	Respiratory, thoracic and mediastinal disorders	Placebo	1	164

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01387607/events?page=2